Tender Details


Tender ID Wound_Closure_3
Description HealthPRO - Wound Closure 3 Contracts commencing June 1, 2020
Tender Docs Location To access tender documents see below.
Tender Document
Addendum Document
Department / Agency Name HealthPRO Procurement Services
Closing Closing on Wednesday, February 20, 2019  at 01:00 PM  Atlantic Time.

Location:
Opening Opening on  Wednesday, February 20, 2019  at 01:30 PM  Atlantic Time.

Location: same as close location
Posted 04 January 2019
Trade Agreement Agreement on Internal Trade (AIT)
Category Goods: Y  | Services: N  | Construction: N
Pickup Fee N/A
Addendum N
Addendum Notes
Contact RFQInquiries@healthprocanada.com
Memorandum HealthPRO Procurement Services Inc. has posted RFQ for the following contracts:

03063 HEMOSTATS, MECHANICAL/ABSORBABLE, COLLAGEN BASED
03064 HEMOSTATS, MECHANICAL/ABSORBABLE, POLYSACCHARIDE BASED
03065 HEMOSTATS, MECHANICAL/ABSORBABLE, GELATIN BASED
03066 HEMOSTATS, MECHANICAL/ABSORBABLE, OXIDIZED CELLULOSE BASED
03067 HEMOSTATS, FIBRIN SEALANT
03068 HEMOSTATS, FLOWABLE
03069 SEALANTS, SYNTHETIC -GLUTARALDEHYDE BASED
05252 SEALANTS, SYNTHETIC-POLYETHYLENE GLYCOL BASED, VASCULAR
05253 SEALANTS, SYNTHETIC-POLYETHYLENE GLYCOL BASED, NEUROLOGY
05254 SYNTHETIC SEALANTS-ADVANCED HEMOSTATIC/SEALING PAD

The Notice of Request for Qualification (RFQ) can be downloaded from Biddingo.com, Bid # HealthPRO - Wound Closure 3 Contracts commencing June 1, 2020. Please note that any future addendum and/or amendment to this RFQ package will only be posted in Biddingo.com.

HealthPRO Procurement Services Inc. (HealthPRO) is a member owned, national healthcare procurement services organization. Through an establishment of a long term contract with HealthPRO, NSHA/IWK has access to contracts negotiated by HealthPRO for commonly purchased hospital related products.

The posting of HealthPRO competitive RFx documents including but not limited to Request for Qualification, Request for Proposal or Advanced Contract Award Notification documents on the Nova Scotia Tenders page does not signify that NSHA/IWK has or will commit to participate in the posted opportunity. Should NSHA/IWK choose to participate in the posted opportunity, such participation will be subject to existing contracts in place at the time.
Awarded Date 01 June 2020
Awarded Amount $0.00
Awarded Vendor See awarded vendors below
Award Memo Contract Award Notification
Tender No. Wound Closure 3
All Contracts Date of Contract: June 1, 2020 - May 31, 2026
All Contracts Available Option Years: 2 Years
All Contracts Procurement Method Used: RFQ, RFP

Contract 03063 Hemostats, Mechanical/Absorbable, Collagen Based
Awarded Supplier(s) Canadian Hospital Specialties Ltd
Total Value $1,352,526.00

Contract 03064 Hemostats, Mechanical/ Absorbable, Polysaccharide Based
Awarded Supplier(s) "Canadian Hospital Specialties Ltd
Livanova Canada Corp."
Total Value $1,220,976.00

Contract 03065 Hemostats, Mechanical/Absorbable, Gelatin Based
Awarded Supplier(s) "Johnson & Johnson Medical Products
Southmedic Inc."
Total Value $4,752,096.00

Contract 03066 Hemostats, Mechanical/Absorbable, Oxidized Cellulose Based
Awarded Supplier(s) "Johnson & Johnson Medical Products
Southmedic Inc."
Total Value $19,366,692.00

Contract 03067 Hemostats, Fibrin Sealant
Awarded Supplier(s) "Johnson & Johnson Medical Products"
Total Value $6,362,742.00

Contract 03068 Hemostats, Flowable
Awarded Supplier(s) "Baxter Corporation
Johnson & Johnson Medical Products"
Total Value 7,431,780‬

Contract 03069 Sealants, Synthetic - Glutaraldehyde Based
Awarded Supplier(s) CryoLife, Inc
Total Value $2,159,406.00

Contract 05252 Sealants, Synthetic-Polyethylene Glycol Based, Vascular
Awarded Supplier(s) Baxter Corporation
Total Value $7,280,088.00

Contract 05253 Sealants, Synthetic-Polyethelene Glycol Based, Neurology
Awarded Supplier(s) Integra Canada ULC
Total Value $4,736,790.00

Contract 05254 Sealants, Synthetic -Advanced Hemostatic/Sealing Pad
Awarded Supplier(s) Baxter Corporation
Total Value $2,640,870.00

Contract 05402 Hemostats, Fibrin Sealants, with Anti-Fibrinolytic Molecule
Awarded Supplier(s) Baxter Corporation
Total Value $35,018,988.00

Bid Sheet
Status Code Legend
RC - Response Received NT - Response Not Totaled IR - Incomplete Response
No Bids Recorded

Price-based totals are recorded as received at the time of closing. Pricing is subject to review by staff of Procurement for mathematical accuracy. Procurement reserves the right to update totals based on this evaluation and as such the final ranking of vendors may be subject to change.

Note: Adobe Reader is required to properly open and view all documents embedded within the PDF. For best results, Right-Click the "Download PDF" link and select "Save-As" or "Save Target As". If you encounter problems please read this support page.